Technetium GA-II GenerativeAI Design Sets
De novo AI-designed small-molecule ligands docked into therapeutic targets, as protein-ligand complexes (Technetium GA-II platform).
Viewer • Updated • 1.57k • 46Note 1,567 small molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the GID4 substrate-binding pocket (7SLZ). Built against the pocket, not screened from a library. GID4 is one of the few usable E3 handles beyond cereblon and VHL.
Tc-43/CRBN_Binders
Updated • 434Note 221 small molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the cereblon thalidomide-binding domain (the tri-tryptophan glutarimide cavity). Scaffold-constrained generation against the pocket, not a library screen; Vina scores the resulting poses.
Tc-43/Novel_NLRP3_Inhibitor_Designs
Updated • 362Note 176 complexes (101 unique molecules) generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the allosteric site of the NLRP3 NACHT module. Built against the pocket, not selected from a library. No NLRP3 inhibitor is approved.
Tc-43/WRNHelicase_Inhibitor
Updated • 149Note 34 small molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the ATPase site of the WRN helicase domain. Pocket-conditioned construction, not library selection. WRN is the synthetic-lethal dependency of MSI-high tumours.
Tc-43/HIF2_Inhibitor_synthetic
Updated • 402Note 69 small molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the buried PAS-B cavity of HIF-2alpha. Built against the pocket, not screened from a library. HIF-2alpha is one of the very few transcription factors ever successfully drugged.
Tc-43/KRAS_CyclophilinA_MolecularGlue
Updated • 230Note 40 molecular glues generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the KRAS-cyclophilin A tri-complex interface so each molecule bridges both proteins. Built against the interface, not screened - no library contains glues for this surface.
Tc-43/CyclinA_RXL_PPI_BLOCKER
Updated • 394Note 57 small molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the RxL substrate-recruitment groove of cyclin A. A shallow PPI surface with no tractable screening library, so every molecule was constructed against it directly.
Tc-43/novel_myosin_modulator_designs
Updated • 225Note 22 small molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the allosteric modulator site of the beta-cardiac myosin motor domain - the mavacamten mechanism. Pocket-conditioned construction, not a library screen.
Tc-43/ACE2-B0AT1
Updated • 223Note 38 small molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the ACE2 site presented by the ACE2-B0AT1 cryo-EM dimer (6M17). Built against the pocket rather than selected from an existing compound set.
Tc-43/nras-cypa-macrocyclic-glues-GA-II
Viewer • Updated • 180 • 141Note 180 macrocyclic glues generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the NRAS(GMPPNP)-CypA interface (9BG0) with ring closure imposed during generation. All 180 span both proteins. Beyond-Rule-of-5 space no screening library covers.
Tc-43/PDE5_Inhibitor_Designs_2H42
Viewer • Updated • 2.09k • 129Note 2,090 small molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the PDE5A catalytic pocket of the sildenafil co-crystal 2H42. Not screened from a library - built against the pocket, and 100% engage Q817 and F820. Score-filtered set.
Tc-43/Lipoprotein-a-Binder-Designs
Viewer • Updated • 100 • 111Note 100 small molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the lysine-binding site of apo(a) kringle IV-8 (8TCE, 1.07 A). Built against the pocket, not screened. Includes the shared receptor, SDF poses, and a control showing Vina scores are size artifacts here.
Tc-43/SAMTOR_Novel_Target_Designs_GA-II
Viewer • Updated • 196 • 177Note 196 SAM-competitive molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the SAM pocket of a human SAMTOR holo model. Novel target proposed and modelled by Claude Code; with no prior chemical probe there was nothing to screen, so every molecule was built against the pocket.
Tc-43/RPIA_Inhibitor_Designs_GA-II
Viewer • Updated • 21 • 109Note 21 first-in-class molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the active site of an AlphaFold model of human RPIA - a previously undrugged enzyme with nothing to screen against. Target discovery and pocket analysis by Biomni. Vina -8.0 to -8.9 kcal/mol.
Tc-43/GPR75_Inhibitor_Designs_GA-II
Viewer • Updated • 139 • 94Note 139 first-in-class anti-obesity molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the GPR75 extracellular vestibule - the accessible route, since ECL2 occludes the orthosteric pocket. Target proposal and pocket modelling by Apodex AI. Vina -10.0 to -11.7, LE 0.41-0.53.
Tc-43/GPR75_Intracellular_Antagonist_Designs_GA-II
Viewer • Updated • 156 • 208Note 156 molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the intracellular allosteric site of an inactive-state GPR75 model, at the Gaq interface. Built against the site rather than screened. Companion to the extracellular-vestibule set.
Tc-43/VHL_NonProline_Binder_Designs_9GIO
Viewer • Updated • 279 • 103Note 279 VHL binders generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the substrate-recognition pocket of 9GIO with the usual hydroxyproline anchor withheld during generation. Median TPSA 89.6 A2 vs VH032's 111.6, one fewer HBD, for PROTAC warhead replacement.
Tc-43/SMARCA2_VHL_MolecularGlue_Designs_6HAY
Viewer • Updated • 884 • 134Note 884 molecular glues generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the SMARCA2 bromodomain-VHL ternary interface (6HAY) so each molecule spans both partners. 100% engage the Asn1464 acetyl-lysine anchor, 99.9% contact VHL, 834 Murcko scaffolds - diversity no library supplies.
Tc-43/LHCGR_Agonist_Designs_7FIH
Viewer • Updated • 993 • 84Note 993 allosteric agonists generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the transmembrane pocket of active-state LHCGR (7FIH). 49.6% make an aromatic contact with Phe515 - the only pocket position differing from both FSHR and TSHR - which the clinical reference Org 43553 does not.
Tc-43/FSHR_Agonist_Designs_8I2G
Viewer • Updated • 292 • 171Note 292 allosteric agonists generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the transmembrane pocket of active-state FSHR (8I2G). All 292 H-bond the pocket (mean 3.67) where the reference agonist makes none; 87% engage Ser596, the FSHR-unique handle. His615 is missed.
Tc-43/Nav1.7_VSD4_NonAnionic_Designs_8I5G
Viewer • Updated • 459 • 119Note 459 small molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the VSD4 voltage-sensor pocket of human Nav1.7 (8I5G, 2.7 A). Built against the pocket, not screened. Deliberately non-anionic: zero sulfonamides, 96.5% not net-anionic - yet all 459 hold the R1619 gating arginine at 2.89 A median, via a neutral H-bond acceptor instead of the aryl sulfonamide anion.
Tc-43/THRB_Agonist_Designs_1R6G
Viewer • Updated • 188 • 112Note 188 small molecules generated de novo by the Technetium TC-43.ai engine (GA-II), conditioned on the THRbeta ligand-binding pocket (1R6G, 3.0 A). Built against the pocket, not screened. Drug-like neutral parents (median QED 0.82) engaging His435 and the Arg320 arm of the anion cluster - but 0/188 reach the Asn331 side chain, so the set carries no structural basis for beta-over-alpha selectivity. Published with that negative result stated.
Tc-43/ORMDL3_Ceramide_Site_Designs_7YIU
Viewer • Updated • 477 • 366Note 477 GA-II designs for the ORMDL3-SPT ceramide-sensing regulatory site (PDB 7YIU). Asthma / 17q21; objective is de-repression of SPT, not inhibition. Gate columns included: 11/477 satisfy both required pharmacophore features.
Tc-43/STAT6_Binder_Designs_GA-II
Viewer • Updated • 199 • 101Note 199 de novo STAT6 binders designed into the AK-1690 degrader pocket of PDB 9BIG
Tc-43/NEK7_Molecular_Glue_Designs_9NFQ
Viewer • Updated • 434 • 311Note 434 CRBN molecular glue designs on the CRBN-NEK7 interface (9NFQ). 221/433 engage all three cage tryptophans with both face-to-face and face-to-edge pi-stacking - a contact the clinical IMiDs cannot make.
Tc-43/15-PGDH_Inhibitor_Designs_9PFL
Viewer • Updated • 510 • 142Note 510 de novo 15-PGDH inhibitor designs in the PGE2 substrate channel of 9PFL; PLIP interaction analysis against the native co-crystal ligand.